COMPLETED

Steroids in Occipital Nerve Block for Treatment of Headache

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Currently there is limited evidence of benefit for the addition of steroids to occipital nerve blocks for treatment of headache, and not all steroids have been explored. The purpose of this research is to learn more about whether the addition of a specific kind of steroid (dexamethasone) provides any additional benefit to nerve blocks.

Official Title

Treatment of Headache With Occipital Nerve Blocks: Comparison Trial of Anesthetic With or Without Dexamethasone

Quick Facts

Study Start:2023-02-17
Study Completion:2025-06-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05732532

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Treated for headache including but not limited to occipital neuralgia, episodic migraine, chronic migraine and/or cervicogenic headache.
  2. * Stable on preventative medication dosing for at least 1 month prior to occipital nerve block and no change in preventative medication regimen during the course of the study.
  3. * Able to understand the requirements of the study and return for treatment.
  4. * Able to independently provide informed consent.
  1. * Diagnosis of cluster headache according to the International Classification of Headache Disorders 3rd edition.
  2. * Occipital or other cranial nerve block administered within 3 months prior to initiation of study.
  3. * History of adverse reaction or contraindication to any of the study ingredients (bupivacaine, lidocaine, dexamethasone).
  4. * Pregnancy.
  5. * Infection or bleeding at site of injection.
  6. * Cranial bone or cervical spine defects/prior surgeries near injection site that prohibit use of landmark-based technique.

Contacts and Locations

Principal Investigator

Carrie Robertson, MD
PRINCIPAL_INVESTIGATOR
Mayo Clinic

Study Locations (Sites)

Mayo Clinic Minnesota
Rochester, Minnesota, 55905
United States

Collaborators and Investigators

Sponsor: Mayo Clinic

  • Carrie Robertson, MD, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-02-17
Study Completion Date2025-06-01

Study Record Updates

Study Start Date2023-02-17
Study Completion Date2025-06-01

Terms related to this study

Additional Relevant MeSH Terms

  • Headache
  • Occipital Nerve Block